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OBJECTIVE — To study whether there is an association between cognitive impairment and
the relapse rate of foot ulcers in diabetic patients and those with previous foot ulcers.
RESEARCH DESIGN AND METHODS — This single-center prospective study as-
sessed the association of cognitive function and risk for ulcer relapse in 59 patients with
diabetes (mean age 65.1 years, diabetes duration 16.5 years, and A1C 7.4%), peripheral
neuropathy, and a history of foot ulceration. Premorbid and current cognitive functions
were measured (multiple-choice vocabulary test [Lehrl], number-symbol test, mosaic test
[HAWIE-R], and trail-making tests A and B [Reitan]). Prevalence of depression was evalu-
ated retrospectively (diagnoses in patient ﬁles or use of antidepressive medication). Patients
were re-examined after 1 year.
RESULTS — Three patients (5%) died during follow-up (one of sepsis and two of heart
problems).Theremaining56patients(48%)developed27newfootulcerations(78%superﬁcial
ulcerations[Wagnerstage1]).Characteristicsofpatientswithandwithoutulcerrelapsewerenot
different. In a binary logistic regression analysis, cognitive function is not predictive of foot
reulceration.
CONCLUSIONS — Cognitivefunctionisnotanimportantdeterminantoffootreulceration.
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D
iabetic patients and those with a
historyoffootulcersareatriskfor
foot reulceration (1,2). Although
cognitive function is known to be im-
paired in patients with diabetes com-
pared with that in nondiabetic control
subjects (3), no studies have examined
the potential role of cognitive impair-
ment, an important factor for educa-
tional success (4), in the development
or recurrence of diabetic foot ulcers.
Our hypothesis is that cognitive func-
tionisassociatedwiththerelapserateof
foot ulcers in patients with diabetes and
previous foot ulcers.
RESEARCH DESIGN AND
METHODS— This single-center pro-
spective study was performed at a tertiary
care center for diabetes (university hospi-
tal)andapprovedbythelocalethicscom-
mittee. Between October 2003 and June
2004, 69 patients with type 2 diabetes
and previous foot ulcers were included.
All gave written informed consent. Of
these, 68% participated in a structured
patient education program at our clinic.
At baseline, a single investigator per-
formed the neuropsychological testing,
and all patients were examined for new
ulcers 12 months later. Ten patients were
excluded because testing was impossible
(impaired vision [n  7] or Parkinsons
disease and debility [n  3]). Testing as-
sessed premorbid cognitive function
(PCF) using a questionnaire by Wolfram
and Wieczorek (5). Current cognitive
function (CCF) was assessed using the
multiple-choice vocabulary test by Lehrl
(6); the number-symbol test and mosaic
test, which are both part of the Hamburg-
Wechsler Adult Intelligence Scale
(HAWIE-R) (7); and the trail-making test
parts A and B by Reitan (8), an indicator
for cognitive impairment due to brain
damage. Loss of cognitive function was
calculated by subtracting CCF from PCF.
All test results were transferred into intel-
ligence quotient (IQ) points according to
age-related scales (100 IQ points reﬂect
normal intelligence compared with the
general population).
Prevalence of depression was esti-
mated retrospectively by searching for a
diagnosis of depression or use of antide-
pressive drugs in the patient ﬁles. Periph-
eral diabetic neuropathy was diagnosed
using the neuropathy symptom score and
neuropathy disability score by Young et
al. (9). The number of previous foot ul-
cerations was drawn from patient ﬁles,
wound stages classiﬁed according to the
Wagner wound classiﬁcation system (six
stages from no lesion to total necrosis)
(10), retinopathy graded according to the
Early Treatment Diabetic Retinopathy
Study (ETDRS) criteria, and nephropathy
with creatinine clearance and microalbu-
minuria. A1C was measured using high-
performance liquid chromatography
(TOSOH-HLC-723-GHbV; Tosoh, To-
kyo, Japan) (range 4.5–5.9; mean  SD
5.2  0.33%). Blood pressure was mea-
sured with patient seated using an oscil-
lometricsphygmomanometer(OMRON).
SPSS (version 14; Chicago, IL) was
usedforstatisticalanalyses,withP0.05
regarded as signiﬁcant. A 
2 test was per-
formed for categorical data and ordinal
data with less than four categories, the
Mann-Whitney U test for non-normally
distributed data, and the Student’s t test
fornormallydistributeddata.Abinarylo-
gistic regression analysis was performed.
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study patients (39 male, 17 female, all
Caucasian) were as follows: age 65.1 
8.9 years, diabetes duration 16.5  9.1
years,A1C7.381.30%,bloodpressure
149.5  25.3/77.5  13.0 mmHg, num-
ber of antihypertensive drugs 2.5  1.1
(span 0–6), BMI 31.6  4.9 kg/m
2, and
numberofpreviousulcers2.92.4(me-
dian 2.0; span 1–9). Prevalence of severe
neuropathy (neuropathy disability score
7) was present in 75% of patients (n 
44), and 15% (n  9) suffered from dia-
betic osteoarthropathy. Orthopedic foot-
wear was used by 78% (n  46), and
specialized foot care by 80% (n  47).
Peripheral artery disease was present in
53% (n  31), and other macrovascular
problems (past myocardial infarct, car-
diovascular disease, or stroke) in 58%
(n  34). Insulin therapy was used by
90% (n  47), and statins by 49% (n 
29). Low social status (without profes-
sional education and jobless) was re-
corded for 4% (n  2), retirement for
76%(n45),andlivingwithrelativesfor
81% (n  48). Smoker or ex-smoker was
recorded for 64% (n  38), and drinking
two or more alcohol equivalents per day
was 15% (n  9). Those suffering from
nephropathy were 71% (n  42), from
retinopathy51%(n30),andfromboth
microvascular complications 39% (n 
23). A diagnosis of depression and/or an-
tidepressive drugs was prevalent in 14%
(n  8).
The results of neuropsychological
testing are as follows: (results in IQ
points) PCF, 102.0  8.7; CCF, 89.7 
11.1; number-symbol test, 95.3  12.3;
mosaic test, 94.6  14.1; and trail-
making test, 67.5  13.5. After 12
months, three patients had died (sepsis,
heart insufﬁciency, or sudden cardiac
death). New foot lesions occurred in 27
patients (48%); 3 (5%) underwent a
minor amputation (two toes and one
forefoot).
The remaining 56 patients with and
without ulcer relapse were not different
for neuropsychological testing or other
characteristics(resultsinTable1).Cogni-
tive function was not predictive for ulcer
relapse in the binary logistic regression
analysis using ulcer relapse as a depen-
dent variable (odds ratio [95% CI] PCF
0.99 [0.94–1.06], CCF 0.99 [0.04–
1.04], loss of cognitive function 1.01
[0.96–1.06], multiple-choice vocabulary
test 0.99 [0.96–1.02], number-symbol
test 0.98 [0.94–1.02], mosaic test 0.99
[0.96–1.04], trail-making test 1.0 [0.97–
1.05]). Adjusting for age, diabetes dura-
tion, and depression did not alter the
results.
CONCLUSIONS— In this study, no
difference of cognitive function was
found in patients with and without ulcer
relapse. Therefore, a failure of patient ed-
ucation to prevent recurrent foot ulcers
cannot be attributed to reduced cognitive
function.
Patientcharacteristicswerenotdiffer-
ent for ulcer relapse and nonrelapse
patients. This is important because nu-
merous confounders (e.g., age, A1C, dia-
betes duration, blood pressure, smoking,
and alcohol intake) are reported to be as-
sociated with decreased cognitive func-
tion (11) and foot problems (3). For the
study, 48% of patients developed a new
ulceration,whichisinkeepingwithother
reported rates (2,12).
Depression is a major differential di-
agnosis for cognitive dysfunction (13)
and has been shown to have a 30% prev-
alence among diabetic patients with neu-
ropathy (14,15). Results of our study are
limitedinthatthestudydidnotscreenfor
depression. Although an association of
depression with micro- and macrovascu-
lar complications and mortality is de-
scribed (14,15), a direct association of
Table 1—Characteristics of patients with and without ulcer relapse
No ulcer
relapse Ulcer relapse P
n 29 (52) 27 (48)
Sex (male/female) 20 (70)/9 (31) 19 (70)/8 (30) 1.0
Age (years) 65.3  7.9 63.8  9.6 0.52
Diabetes duration (years) 14.9  6.6 18.2  10.9 0.18
Weight (kg) 90.5  15.6 97.9  18.6 0.11
BMI (kg/m
2) 31.4  4.7 32.4  5.0 0.44
A1C (%) 7.6  1.5 7.1  0.8 0.16
Systolic blood pressure (mmHg) 144.6  28.2 155.41  21.4 0.11
Diastolic blood pressure (mmHg) 75.7  13.6 80.1  12.7 0.21
Severe neuropathy 22 (76) 20 (74) 0.88
Number of previous foot ulcers 2.5  2.0 3.0  2.6 0.34
Prior amputation 10 (35) 8 (30) 0.78
Osteoarthropathy (Charcot foot) 4 (14) 4 (15) 1.0
Use of orthopedic footwear 23 (79) 21 (78) 1.0
No podiatric care 9 (31) 3 (11) 0.07
Received structured patient education 19 (66) 19 (70) 0.7
Diagnosis of depression or use of
antidepressive drugs 5 (17) 3 (11) 0.5
Retinopathy 12 (41) 15 (56) 0.42
Nephropathy 18 (62) 21 (78) 0.54
Dialysis 1 (4) 1 (4) 1.0
Microvascular complications* 8 (28) 12 (44) 0.19
Peripheral vascular disease 17 (59) 12 (44) 0.42
Use of statins 16 (55) 12 (44) 0.30
Use of insulin 26 (90) 22 (82) 0.46
Low social status** 2 (7) 0 (0) 0.49
Alcohol 2 drinks/day 4 (14) 5 (19) 0.73
Current smoker or ex-smoker 19 (66) 18 (67) 1.0
Cognitive function in IQ points
PCF 102.1  8.92 102.0  8.88 0.98
CCF 91.8  12.3 90.6  9.8 0.67
Loss of cognitive function 10.3  10.3 11.5  11.4 0.67
Multiple-choice vocabulary test 107.0  18.0 103.8  14.2 0.47
Number-symbol test 97.2  13.7 94.3  10.7 0.37
Mosaic test 95.7  15.9 95.4  11.3 0.93
Trail-making test A 67.4  13.2 68.3  15.3 0.80
Trail-making test B 67.5  15.5 69.4  15.9 0.64
Data are means  SD or n (%). Values for cognitive function represent IQ points. *Patients with retinopathy
and nephropathy. **Patients without professional education and jobless. NDS, neuropathy disability score.
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betic foot ulcers was not reported (13–
15).Inaposthocanalysesusingdiagnosis
of depression or use of an antidepressant
medicationasanindicatorfordepression,
these patients were evenly distributed in
the ulcer-relapse and non–ulcer-relapse
groups. Nevertheless, the prevalence of
depression is likely to be underestimated,
which possibly affects the results. In con-
clusion, this study does not support the
commonly held belief that cognitive dys-
function is an important determinant of
foot reulceration.
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